Dogwood Therapeutics Inc
DWTX
Company Profile
Business description
Dogwood Therapeutics Inc, formerly Virios Therapeutics Inc, is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a virus-triggered abnormal immune response, such as fibromyalgia (FM) and long COVID (LC). Its product candidates include IMC-1 and IMC-2. IMC-1 is intended to synergistically suppress herpesvirus activation and replication with a more specific activity against the Epstein-Barr virus (herpesvirus HHV-4, IMC-2 is a combination of valacyclovir and celecoxib.
Contact
44 Milton Avenue
AlpharettaGA30009
USAT: +1 866 620-8655
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
12
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,743.60 | 30.00 | -0.34% |
CAC 40 | 7,691.55 | 134.24 | 1.78% |
DAX 40 | 24,033.22 | 383.92 | 1.62% |
Dow JONES (US) | 43,819.27 | 432.43 | 1.00% |
FTSE 100 | 8,798.91 | 63.31 | 0.72% |
HKSE | 24,284.15 | 41.25 | -0.17% |
NASDAQ | 20,273.46 | 105.55 | 0.52% |
Nikkei 225 | 40,150.79 | 566.21 | 1.43% |
NZX 50 Index | 12,583.59 | 103.54 | 0.83% |
S&P 500 | 6,173.07 | 32.05 | 0.52% |
S&P/ASX 200 | 8,514.20 | 36.60 | -0.43% |
SSE Composite Index | 3,424.23 | 24.23 | -0.70% |